Novella, a clinical neurologist at Yale University School of Medicine and editor of Science-Based Medicine, reviewed the accumulated earthing literature. He concluded that the research base consists almost entirely of small pilot studies with sample sizes of 8-40 subjects, uses weak methodology, and shows a consistent pattern where more rigorous designs produce weaker results. He noted that after over 15 years of research, no large-scale randomized controlled trial (100+ participants) has ever been published, which is highly unusual for a legitimate therapeutic claim. He described the field as an example of "what is wrong with biomedical publishing" - favoring publication of many low-quality studies to create an appearance of legitimacy.

Published conflict-of-interest statements in the 2015 Journal of Inflammation Research paper and other earthing publications disclose that Gaetan Chevalier and James Oschman are independent contractors for EarthFx Inc. and hold shares in the company. Clinton Ober, who popularized the earthing concept and funded much of the research, is the CEO of a company that sells grounding mats, sheets, and other products. Nearly all published earthing studies have direct financial ties to the earthing product industry. This creates a significant bias concern, as researchers stand to profit from positive results.

The Cleveland Clinic, a major academic medical center, published an assessment noting that earthing "should always be a complement to - not a replacement for - evidence-based medicine." The institution states that the specific anti-inflammatory and healing claims connected to earthing practice are unproven by rigorous research. They suggest that reported benefits may be attributable to confounding factors such as spending time outdoors, relaxation, walking barefoot on natural surfaces, or placebo effects rather than any electron transfer mechanism. They also warn people with pacemakers or implanted electrical devices to avoid grounding mats.

Multiple physicists and pharmaceutical scientists have examined the proposed mechanism behind earthing claims. The analysis found that: (1) the earth is not a "giant electric battery" that donates electrons to living organisms; (2) "electron deficiency" is not a recognized medical or physiological condition; (3) there is no established mechanism by which standing on the ground would transfer clinically relevant numbers of electrons into the body; and (4) if the electron transfer theory were correct, basic chemistry and physics would not function as observed. The electrons in the body and the electrons in the ground are identical - there is no special property of "earth electrons."

Dr. Greta Raglan, Clinical Associate Professor of Psychiatry at the University of Michigan Medical School, assessed the grounding literature. She noted that across all published studies, sample sizes are extremely small (typically 8-40 participants), making it impossible to draw reliable conclusions. She stated: "It wasn''t like everybody had insomnia and then was magically recovered because they used these devices." The assessment emphasized methodological limitations including difficulty blinding participants (people may sense whether they are electrically connected to the earth), lack of independent replication, and no established safety data for grounding products.

Africa Check, a fact-checking organization, evaluated the evidence for earthing claims. They concluded that while some small studies show positive results, the overall evidence base is insufficient to support the anti-inflammatory claims being made. Most studies have 10-40 subjects, which is far below the sample sizes of hundreds or thousands that mainstream medicine expects before accepting a therapeutic claim. They noted the absence of independent replication by researchers without financial ties to the earthing industry as a critical gap.

Multiple methodological reviews have identified a fundamental design flaw in earthing research: it is extremely difficult to create a convincing placebo. "Sham" grounding connections (disconnected wires) provide imperfect blinding because some participants can sense differences in static discharge, temperature, or tingling when actually grounded. Without effective blinding, participants who believe they are grounded may report improvements due to expectation alone. This placebo problem, combined with the fact that most studies rely heavily on subjective self-reported outcomes like pain and sleep quality, means that positive results cannot be confidently attributed to the grounding intervention itself.

As of 2025, earthing or grounding is not recommended by any major medical organization including the WHO, NIH, FDA, NHS, or any national medical association. It does not appear in any clinical practice guideline for treating inflammation, autoimmune disease, or any other condition. The FDA has not approved any grounding device as a medical device. The NIH''s National Center for Complementary and Integrative Health does not list earthing among its researched therapies. This absence from mainstream medical recommendations reflects the consensus that the evidence base is insufficient to support therapeutic claims.

The Sleep Foundation, a health information organization with medical review oversight, assessed the evidence for grounding products. They noted that the scientific evidence remains preliminary and is contested by mainstream medical professionals. They highlighted that there is no independent data about the safety or efficacy of grounding products. Most studies are too small to draw meaningful conclusions, and the few that exist have not been independently replicated by researchers without ties to the grounding product industry. They advise consumers to approach grounding claims with caution.